What are you looking for today?

Gil, Veronica S, Bhagat, Govind, Howell, Louise, Zhang, Jiyuan, Kim, Chae H, Stengel, Sven, Vega, Francisco, Zelent, Arthur and Petrie, Kevin (2016) Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice. Disease models & mechanisms, 9 (12). pp. 1483-1495. ISSN 1754-8411

Document

  • [thumbnail of 2016 Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice + SI.pdf]
    2016 Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice + SI.pdf - Published Version
    Available under License Creative Commons Attribution.

Abstract

Abstract

Histone deacetylase 9 (HDAC9) is expressed in B cells, and its overexpression has been observed in B-lymphoproliferative disorders, including B-cell non-Hodgkin lymphoma (B-NHL). We examined HDAC9 protein expression and copy number alterations in primary B-NHL samples, identifying high HDAC9 expression among various lymphoma entities and HDAC9 copy number gains in 50% of diffuse large B-cell lymphoma (DLBCL). To study the role of HDAC9 in lymphomagenesis, we generated a genetically engineered mouse (GEM) model that constitutively expressed an HDAC9 transgene throughout B-cell development under the control of the immunoglobulin heavy chain (IgH) enhancer (Eμ). Here, we report that the Eμ-HDAC9 GEM model develops splenic marginal zone lymphoma and lymphoproliferative disease (LPD) with progression towards aggressive DLBCL, with gene expression profiling supporting a germinal center cell origin, as is also seen in human B-NHL tumors. Analysis of Eμ-HDAC9 tumors suggested that HDAC9 might contribute to lymphomagenesis by altering pathways involved in growth and survival, as well as modulating BCL6 activity and p53 tumor suppressor function. Epigenetic modifications play an important role in the germinal center response, and deregulation of the B-cell epigenome as a consequence of mutations and other genomic aberrations are being increasingly recognized as important steps in the pathogenesis of a variety of B-cell lymphomas. A thorough mechanistic understanding of these alterations will inform the use of targeted therapies for these malignancies. These findings strongly suggest a role for HDAC9 in B-NHL and establish a novel GEM model for the study of lymphomagenesis and, potentially, preclinical testing of therapeutic approaches based on histone deacetylase inhibitors.

Item Type: Article
Depositing User: Kevin Petrie
URI: https://sure.sunderland.ac.uk/id/eprint/12446

Further Details

More Information

Depositing User

Identifiers

Item ID
12446
Identification Number
ISSN
1754-8411

Users with ORCIDS

ORCID for Kevin Petrie

Catalogue record

Date Deposited
18 Aug 2020 19:09
Last Modified
04 Jun 2025 16:17

Contributors

Author
Veronica S Gil
Author
Govind Bhagat
Author
Louise Howell
Author
Jiyuan Zhang
Author
Chae H Kim
Author
Sven Stengel
Author
Francisco Vega
Author
Arthur Zelent

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year